News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Continue Reading Previous Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories Brain Clinical Trial Healthcare News Pharmaceutical Pregnancy Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients Staff November 23, 2024 Healthcare Hospitals News Nursing Patient Care Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring Staff November 23, 2024 Apps Financial Fitness News Nutrition Fitness App Market to Expand by USD 55.86 Billion (2024-2028), Driven by Health Management and Rising Chronic Disease Cases, AI Impacting Market Trends – Technavio Staff November 23, 2024
